Storia in 6 fonti

Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines

Moderna’s upsized note offering quickly followed a big win in a crucial study. Elsewhere, a biotech’s shares tumbled after study data were “inadvertently” published ahead of a medical meeting.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo2 g fa

Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines

originale

Timeline cronologica

martedì 25 agosto 2026·morningstar.com
Health Care Up as Biotech Momentum Persists — Health Care Roundup
Health-care companies rose as the biotech sub-sector gathered momentum.
giovedì 27 agosto 2026·qz.com
Moderna raises $2 billion in convertible notes for cancer vaccine
The biotech company will sell notes due 2032, with an option to raise an additional $300 million, days after its stock hit a multi-year high

Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines

Confronto fonti

Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines

Timeline cronologica

Health Care Up as Biotech Momentum Persists — Health Care Roundup

Moderna raises $2 billion in convertible notes for cancer vaccine

Moderna's $2B offering; AstraZeneca-Amgen and Biokin chalk up Phase 3 wins

Moderna raises $2 billion in convertible notes for cancer vaccine

Moderna Borrows $2 Billion To Expand Oncology Business - Moderna (NASDAQ:MRNA)

What’s in Merck and Moderna’s cancer vaccine algorithm?

Health Care Up as Biotech Momentum Persists — Health Care Roundup

Moderna Borrows $2 Billion To Expand Oncology Business - Moderna (NASDAQ:MRNA)

What’s in Merck and Moderna’s cancer vaccine algorithm?

Moderna's $2B offering; AstraZeneca-Amgen and Biokin chalk up Phase 3 wins

Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines